Clinical Trials
384 trialsTARLATEM
Centre Leon Berard
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
St. Jude Children's Research Hospital
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Baptist Health South Florida
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
A Study of Mirdametinib in People With Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
iCaRe2
University of Nebraska
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
St. Jude Children's Research Hospital
Short Course Radiotherapy
Abramson Cancer Center at Penn Medicine
PPROSPERITIT
Masaryk University
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital
JACOB
Children's National Research Institute
Expanded Access [11C] Methionine PET Imaging
St. Jude Children's Research Hospital
Characterizing Sleep Among Long-term Survivors of Childhood Cancer
St. Jude Children's Research Hospital
Cerebrospinal Fluid Biomarkers for Brain Tumors
Mayo Clinic
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Washington University School of Medicine
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Massachusetts General Hospital
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Seattle Children's Hospital
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nationwide Children's Hospital
ReRT
The New York Proton Center
Patient and Caregiver Priorities in Neuro-oncology Care
Mayo Clinic
ASAP
Avera McKennan Hospital & University Health Center
PNOC023
University of California, San Francisco
Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance
Chang Gung Memorial Hospital
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
M.D. Anderson Cancer Center
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
OHSU Knight Cancer Institute
A Study of Avutometinib for People With Solid Tumor Cancers
Memorial Sloan Kettering Cancer Center
NEMO
Tata Memorial Centre
Study of Human Brain-Gut Axis and Gut Microbiome in Patients With Brain Lesions - Repository for Neuroscience Research
Mayo Clinic
B7-H3.CD28Z.CART in CNS Neoplasms
Dana-Farber Cancer Institute
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
FUS Etoposide for DMG
Columbia University
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Australian & New Zealand Children's Haematology/Oncology Group
Niraparib in Tumors Metastatic to the CNS
Massachusetts General Hospital
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Alliance for Clinical Trials in Oncology
TECAP
Centre Hospitalier Universitaire de la Réunion
FCBTR
University of Florida
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
M.D. Anderson Cancer Center
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Seattle Children's Hospital
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Seattle Children's Hospital
Tissue Collection for Drug Screening and Bioanalysis
Weill Medical College of Cornell University
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
Memorial Sloan Kettering Cancer Center
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
DOMINO-START
Weill Medical College of Cornell University
Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors
Seattle Children's Hospital
Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment
Massachusetts General Hospital
Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation
Mayo Clinic
Study of Stored Tumor Samples in Young Patients With Brain Tumors
St. Jude Children's Research Hospital